SCHEMBL30846478

SCHEMBL30846478

CC(=O)c1ccc(S(=O)(=O)Nc2cccc3cnn(C)c23)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.41
▸ SLC40A1 Q9NP59 6/20 0.40
▸ MMP2 P08253 2/20 0.40
▸ NAMPT P43490 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ BDKRB1 P46663 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SLC16A3 O15427 1/20 0.38
▸ MITF O75030 1/20 0.38
▸ S1PR4 O95977 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ S1PR1 P21453 1/20 0.38
▸ AGTR1 P30556 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ CKS1B P61024 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SKP2 Q13309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27126473 1.00 TDP1 (0.41) TDP1SLC40A1MMP2NAMPTLMNA
SCHEMBL27125948 0.84 TDP1 (0.41) TDP1SLC40A1MMP2LMNAMAPK1
SCHEMBL30846365 0.84 SLC40A1 (0.41) TDP1SLC40A1MMP2NAMPTLMNA
SCHEMBL27126476 0.84 SLC40A1 (0.41) TDP1SLC40A1MMP2NAMPTLMNA
SCHEMBL30846193 0.83 GAA (0.55) TDP1SLC40A1LMNAMAPK1GAA
SCHEMBL27123592 0.83 GAA (0.55) TDP1SLC40A1LMNAMAPK1GAA
SCHEMBL27125153 0.82 L3MBTL1 (0.40) TDP1SLC40A1NAMPTSLC16A3ALDH1A1
SCHEMBL30846304 0.82 L3MBTL1 (0.40) TDP1SLC40A1NAMPTSLC16A3ALDH1A1
SCHEMBL30846268 0.82 TDP1 (0.36) TDP1SLC40A1LMNAMAPK1GAA
SCHEMBL27154166 0.82 TDP1 (0.36) TDP1SLC40A1LMNAMAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044344-A1 PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback